Prediction of BK Virus Reactivation in Kidney Transplant Recipient

Last updated: March 3, 2025
Sponsor: King Chulalongkorn Memorial Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

BKV immune monitoring

Clinical Study ID

NCT06219616
BKV-KCMH
  • Ages > 18
  • All Genders

Study Summary

There has been no effective predicting tool to accurately predict BKV reactivation after kidney transplantation. The aim is to elucidate the use of flow cytometric analysis for both intracellular cytokines and surface activation markers for BKV-specific T cell response in kidney transplant recipients.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. New kidney transplantation cases (either living donor or deceased donortransplantation)

  2. Age ≥ 18 years old

  3. Agree to give a permission to blood sampling post-transplantation, and at the timeof BK viremia.

Exclusion

Exclusion criteria:

  1. Pregnant

  2. Primary non-function of kidney allograft (i.e. kidney allograft never function).

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: BKV immune monitoring
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • King Chulalongkorn Memorial Hospital

    Bangkok, 10330
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.